Adoptive Immuntherapie der akuten ADV-Infektion nach allogener Knochenmark- oder peripherer Blutstammzelltransplantation - ÎAKS
Active, not recruiting
- Conditions
- Adenovirus infection following allogeneic stem cell transplantation.
- Registration Number
- EUCTR2005-001092-35-DE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Adenovirus infection following allogeneic stem cell transplantation.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
GvHD III-IV at the time of T-cell transfer.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Safety of adoptive transfer of virus specific T-cells from the donor of the allogeneic stem cell transplantation.;Secondary Objective: Initial evidence of the efficacy using adoptive transfer of virus specific T-cells from the donor of the allogeneic stem cell transplantation.;Primary end point(s): Evaluable safety data on 20-30 patients.
- Secondary Outcome Measures
Name Time Method